Skip to main content

Taysha Gene Therapies, Inc 10-K for FY2022

Taysha Gene Therapies, Inc. (TSHA)

10-K 2023-03-28 For: 2022-12-31
View Original
Added on April 07, 2026

About this 10-K

Taysha Gene Therapies, Inc filed this 10-K on March 28, 2023, covering the fiscal year ended December 31, 2022 (FY2022).

Headline figures

Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.5M
Net loss
$166.01M
compared with a net loss of $174.52M a year earlier
Diluted EPS
-$3.78
compared with -$4.64 a year earlier